XML 47 R30.htm IDEA: XBRL DOCUMENT v3.23.3
Goodwill and Other Intangible Assets (Tables)
6 Months Ended
Sep. 02, 2023
Goodwill and Other Intangible Assets  
Summary of the changes in the carrying amount of goodwill

​

​

​

​

​

​

​

​

​

​

​

​

    

Retail

    

Pharmacy

    

​

​

​

​

Pharmacy

​

Services

​

Total

Balance, March 4, 2023

​

​

43,492

​

​

464,444

​

​

507,936

Goodwill impairment

​

​

—

​

​

(417,500)

​

​

(417,500)

Balance, September 2, 2023

​

$

43,492

​

$

46,944

​

$

90,436

Schedule of indefinite-lived intangible assets

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

September 2, 2023

​

March 4, 2023

​

​

​

​

​

​

​

​

​

​

​

Remaining

​

​

​

​

​

​

​

​

​

​

Remaining

​

​

​

​

​

​

​

​

​

​

​

Weighted

​

​

​

​

​

​

​

​

​

​

Weighted

​

​

Gross

​

​

​

​

​

​

​

Average

​

Gross

​

​

​

​

​

​

​

Average

​

​

Carrying

​

Accumulated

​

​

​

​

Amortization

​

Carrying

​

Accumulated

​

​

​

​

Amortization

​

    

Amount

    

Amortization

    

Net

    

Period

    

Amount

    

Amortization

    

Net

    

Period

Non-compete agreements and other(a)

​

$

203,632

​

$

(184,551)

​

$

19,081

​

3

years

​

$

201,919

​

$

(182,957)

​

$

18,962

​

3

years

Prescription files

​

 

1,030,619

​

​

(935,466)

​

​

95,153

 

5

years

​

 

1,029,665

​

​

(928,478)

​

​

101,187

 

5

years

Customer relationships(a)

​

​

386,000

​

​

(313,062)

​

​

72,938

​

8

years

​

​

388,000

​

​

(306,139)

​

​

81,861

​

9

years

CMS license

​

​

57,500

​

​

(57,500)

​

​

—

​

0

years

​

​

57,500

​

​

(23,798)

​

​

33,702

​

4

years

Total finite

​

$

1,677,751

​

$

(1,490,579)

​

​

187,172

​

​

​

​

$

1,677,084

​

$

(1,441,372)

​

$

235,712

​

​

​

Trademarks

​

​

14,400

​

​

—

​

​

14,400

​

Indefinite

​

​

​

14,400

​

​

—

​

​

14,400

​

Indefinite

​

Total

​

$

1,692,151

​

$

(1,490,579)

​

$

201,572

​

​

​

​

$

1,691,484

​

$

(1,441,372)

​

$

250,112

​

​

​

(a)Amortized on an accelerated basis which is determined based on the remaining useful economic lives of the customer relationships that are expected to contribute directly or indirectly to future cash flows.
Schedule of finite-lived intangible assets

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

September 2, 2023

​

March 4, 2023

​

​

​

​

​

​

​

​

​

​

​

Remaining

​

​

​

​

​

​

​

​

​

​

Remaining

​

​

​

​

​

​

​

​

​

​

​

Weighted

​

​

​

​

​

​

​

​

​

​

Weighted

​

​

Gross

​

​

​

​

​

​

​

Average

​

Gross

​

​

​

​

​

​

​

Average

​

​

Carrying

​

Accumulated

​

​

​

​

Amortization

​

Carrying

​

Accumulated

​

​

​

​

Amortization

​

    

Amount

    

Amortization

    

Net

    

Period

    

Amount

    

Amortization

    

Net

    

Period

Non-compete agreements and other(a)

​

$

203,632

​

$

(184,551)

​

$

19,081

​

3

years

​

$

201,919

​

$

(182,957)

​

$

18,962

​

3

years

Prescription files

​

 

1,030,619

​

​

(935,466)

​

​

95,153

 

5

years

​

 

1,029,665

​

​

(928,478)

​

​

101,187

 

5

years

Customer relationships(a)

​

​

386,000

​

​

(313,062)

​

​

72,938

​

8

years

​

​

388,000

​

​

(306,139)

​

​

81,861

​

9

years

CMS license

​

​

57,500

​

​

(57,500)

​

​

—

​

0

years

​

​

57,500

​

​

(23,798)

​

​

33,702

​

4

years

Total finite

​

$

1,677,751

​

$

(1,490,579)

​

​

187,172

​

​

​

​

$

1,677,084

​

$

(1,441,372)

​

$

235,712

​

​

​

Trademarks

​

​

14,400

​

​

—

​

​

14,400

​

Indefinite

​

​

​

14,400

​

​

—

​

​

14,400

​

Indefinite

​

Total

​

$

1,692,151

​

$

(1,490,579)

​

$

201,572

​

​

​

​

$

1,691,484

​

$

(1,441,372)

​

$

250,112

​

​

​

(a)Amortized on an accelerated basis which is determined based on the remaining useful economic lives of the customer relationships that are expected to contribute directly or indirectly to future cash flows.